I 
118TH CONGRESS 
1ST SESSION H. R. 1305 
To direct the Secretary of Health and Human Services, in consultation 
with the Secretary of State, to formulate a strategy for the Federal 
Government to secure support from foreign countries, multilateral organi-
zations, and other appropriate entities to facilitate the development and 
commercialization of qualified pandemic or epidemic products, and for 
other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MARCH 1, 2023 
Mr. LEVIN (for himself, Mr. FERGUSON, Mr. MCGOVERN, and Mr. AMODEI) 
introduced the following bill; which was referred to the Committee on 
Foreign Affairs 
A BILL 
To direct the Secretary of Health and Human Services, 
in consultation with the Secretary of State, to formulate 
a strategy for the Federal Government to secure support 
from foreign countries, multilateral organizations, and 
other appropriate entities to facilitate the development 
and commercialization of qualified pandemic or epidemic 
products, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
22:38 Mar 16, 2023
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H1305.IH
H1305
kjohnson on DSK79L0C42PROD with BILLS
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Saving Us from Pan-
demic Era Resistance by Building a Unified Global Strat-
egy Act of 2023’’ or the ‘‘SUPER BUGS Act of 2023’’. 
SEC. 2. INTERNATIONAL STRATEGY FOR DEVELOPMENT OF 
QUALIFIED PANDEMIC OR EPIDEMIC PROD-
UCTS. 
(a) STRATEGY.— 
(1) IN GENERAL.—Not later than 18 months 
after the date of enactment of this Act, the Sec-
retary of Health and Human Services, in consulta-
tion with the Secretary of State, shall— 
(A) formulate a strategy for the Federal 
Government to secure support from foreign 
countries, multilateral organizations, and other 
appropriate entities to facilitate the develop-
ment and commercialization of qualified pan-
demic or epidemic products, including such 
products to address antimicrobial resistant 
pathogens— 
(i) with pandemic potential; or 
(ii) that are priority pathogens; and 
(B) submit such strategy to the appro-
priate committees of Congress. 
(2) CONTENTS.—The strategy under paragraph 
(1) shall— 
VerDate Sep 11 2014 
22:38 Mar 16, 2023
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H1305.IH
H1305
kjohnson on DSK79L0C42PROD with BILLS
(A) provide for the process the Federal 
Government would use to enter into arrange-
ments with foreign countries, multilateral orga-
nizations, and other appropriate entities in cer-
tain circumstances; 
(B) strive to secure equitable contributions 
among participating countries, organizations, 
and entities; 
(C) focus on global priorities but allow par-
ticipating countries, organizations, and entities 
to emphasize national or regional issues of im-
portance; 
(D) seek to ensure such arrangements are 
harmonized with each other and with other rel-
evant arrangements to prevent duplication of 
effort and to efficiently distribute funds; 
(E) provide for collaboration so as to allo-
cate joint or individual responsibility across 
participating countries, organizations, and enti-
ties for the development and commercialization 
of particular qualified pandemic or epidemic 
products, where such collaboration is spelled 
out beforehand in such arrangements; 
VerDate Sep 11 2014 
22:38 Mar 16, 2023
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H1305.IH
H1305
kjohnson on DSK79L0C42PROD with BILLS